Zu den Inhalten springen
Marien Hospital Herne
St. Elisabeth Gruppe
HomeHome
Klinik für Urologie

Seagan

A Single-arm, Open-label, Multicenter Study of Enfortumab Vedotin (ASG-22CE) for Treatment of Patients With Locally Advanced or Metastatic Urothelial Cancer Who Previously Received Immune Checkpoint Inhibitor (CPI) Therapy

© Marien Hospital Herne | Impressum | . Datenschutz | . Datenschutz­einstellungen anpassen.